Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Why Earnings Season Could Be Great for Eli Lilly (LLY)
09:54am, Wednesday, 26'th Apr 2023
Eli Lilly (LLY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer's drug space, CEO says
01:40pm, Tuesday, 25'th Apr 2023
Biogen CEO Christopher Viehbacher said during an earnings call that Eli Lilly needs to consider maintenance doses its Alzheimer's treatment donanemab.
2 Monster Stocks to Buy Without Any Hesitation
10:20am, Tuesday, 25'th Apr 2023
Eli Lilly's shares are up more than 235% over the past five years. Mounjaro is expected to be a blockbuster drug for Lilly.
Better Buy: Novo Nordisk vs. Eli Lilly
05:17am, Tuesday, 25'th Apr 2023
Sales of Novo Nordisk's diabetes drug and weight-management drugs are soaring. Eli Lilly's popular new diabetes drug, Mounjaro, could soon earn approval to address chronic weight management.
Novo Nordisk Sinks As Eli Lilly Plots Its Showdown In The Red-Hot Obesity Shot Race
01:13pm, Monday, 24'th Apr 2023
Novo Nordisk stock dipped Monday after Eli Lilly posted the details of its study comparing Mounjaro and Wegovy in obesity treatment. The post Novo Nordisk Sinks As Eli Lilly Plots Its Showdown In The
Eli Lilly to sell Baqsimi diabetes drug to Amphastar for around $1 billion
12:30pm, Monday, 24'th Apr 2023
Eli Lilly and Co (NYSE:LLY) revealed that it will sell Baqsimi, its nasal treatment for severe hypoglycemia in people with diabetes, to Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) for around $1 billio
Eli Lilly (LLY) to Report Q1 Earnings: Will It Beat Estimates?
12:12pm, Monday, 24'th Apr 2023
Higher demand for its key drugs is likely to have offset generic competition for several drugs and may have boosted Lilly's (LLY) first-quarter sales.
Eli Lilly to sell hypoglycemia treatment for up to $1.1 billion in cash and milestone payments to Amphastar
06:54am, Monday, 24'th Apr 2023
Shares of Eli Lilly & Co. LLY gained 0.5% in premarket trading Monday, after the drugmaker announced an agreement to sell its hypoglycemia treatment for people with diabetes Baqsimi to Amphastar Pharm
3 Stocks With Huge Catalysts on the Way
06:18am, Saturday, 22'nd Apr 2023
Axsome Therapeutics has several major milestones around the corner. CRISPR Therapeutics could soon win approvals for its first product.
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
10:41am, Friday, 21'st Apr 2023
Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Investing Your Tax Refund? These 2 Stocks Can Make the Most of Your Money
10:23am, Thursday, 20'th Apr 2023
Eli Lilly and Apple are cash-rich businesses that can afford to pay dividends and invest in the future. Mounjaro is a weight-loss treatment that could bring in tens of billions in revenue for Eli Lill
Is Eli Lilly Stock a Buy Now?
08:45am, Thursday, 20'th Apr 2023
Eli Lilly has faced a series of issues over the past few months. But the drugmaker's pipeline still looks promising.
SNY vs. LLY: Which Stock Is the Better Value Option?
12:56pm, Monday, 17'th Apr 2023
Investors looking for stocks in the Large Cap Pharmaceuticals sector might want to consider either Sanofi (SNY) or Eli Lilly (LLY). But which of these two companies is the best option for those lookin
Here are 2 Top Drug Makers Leading the Way in Weight Loss Drugs
07:01am, Monday, 17'th Apr 2023
The topic of weight loss drugs has been making recent headlines. The positive phase 1 clinical trial for Viking Therapeutics Inc. (NASDAQ: VKTX) GLP-1 treatment VK2735 caused its shares to rally more
Get In Now. 3 Stocks That Are Set to Soar.
08:30am, Sunday, 16'th Apr 2023
As the market shows some stability, investors are looking for stocks to buy for the long term. Some great stocks remain undervalued and look like bargains at their current prices, but for how long?
